Accelera

Accelera is a premium tier Contract Research Organization (CRO) working and collaborating with more than 300 pharmaceutical and biotechnology companies around the world.

Accelera provides customer tailored services to select the best drug candidates and develop NCEs, NBEs, Biosimilars, and Cell Based Therapies, running optimised IND enabling studies, as well as reproductive toxicology and ADME studies.

Fully compliant to international guidelines, Accelera has a strong track record of regulated activities recognized by the major Agencies, including EMA, FDA, KFDA, MHLW. 

Need more information?